Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
Go back to Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks| (NASDAQ: TRAW) | Delayed: 0.84 -0.05 (5.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.89 | 52 Week High | $ | |||
| Open | $0.87 | 52 Week Low | $ | |||
| Day High | $0.95 | P/E | N/A | |||
| Day Low | $0.84 | EPS | $ | |||
| Volume | 262,224 | |||||

